H. Elzinga

746 total citations
23 papers, 594 citations indexed

About

H. Elzinga is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, H. Elzinga has authored 23 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in H. Elzinga's work include Diet and metabolism studies (6 papers), Muscle activation and electromyography studies (3 papers) and Digestive system and related health (3 papers). H. Elzinga is often cited by papers focused on Diet and metabolism studies (6 papers), Muscle activation and electromyography studies (3 papers) and Digestive system and related health (3 papers). H. Elzinga collaborates with scholars based in Netherlands, France and United States. H. Elzinga's co-authors include J.P.K. Halbertsma, At L. Hof, Frans Stellaard, B.G. Wolthers, Marion G. Priebe, Roel J. Vonk, Henkjan J. Verkade, S Pavel, Grant W. Vandenberg and Janneke Heimweg and has published in prestigious journals such as Annals of Oncology, Biochimica et Biophysica Acta (BBA) - General Subjects and Clinica Chimica Acta.

In The Last Decade

H. Elzinga

21 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Elzinga Netherlands 13 251 88 85 82 77 23 594
Masahiro Fujimoto Japan 17 182 0.7× 213 2.4× 137 1.6× 85 1.0× 89 1.2× 68 814
Daijiro Abe Japan 15 187 0.7× 62 0.7× 85 1.0× 62 0.8× 98 1.3× 52 809
D Chaleil France 11 210 0.8× 226 2.6× 23 0.3× 38 0.5× 28 0.4× 28 704
Hajime Ito Japan 11 126 0.5× 188 2.1× 120 1.4× 61 0.7× 46 0.6× 33 601
M. D. Weidner United States 5 100 0.4× 52 0.6× 72 0.8× 38 0.5× 119 1.5× 6 345
Chu‐Fen Chang Taiwan 11 122 0.5× 68 0.8× 60 0.7× 65 0.8× 20 0.3× 19 381
Dimitris Mandalidis Greece 15 119 0.5× 38 0.4× 74 0.9× 185 2.3× 110 1.4× 43 858
Özlem Bölgen Çımen Türkiye 14 47 0.2× 13 0.1× 101 1.2× 118 1.4× 82 1.1× 35 687
Miroslav Petr Czechia 17 122 0.5× 29 0.3× 69 0.8× 80 1.0× 319 4.1× 50 901
J. Mark Brown Australia 20 344 1.4× 35 0.4× 253 3.0× 556 6.8× 95 1.2× 41 1.3k

Countries citing papers authored by H. Elzinga

Since Specialization
Citations

This map shows the geographic impact of H. Elzinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Elzinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Elzinga more than expected).

Fields of papers citing papers by H. Elzinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Elzinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Elzinga. The network helps show where H. Elzinga may publish in the future.

Co-authorship network of co-authors of H. Elzinga

This figure shows the co-authorship network connecting the top 25 collaborators of H. Elzinga. A scholar is included among the top collaborators of H. Elzinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Elzinga. H. Elzinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verheij, Marcel, Arash Navran, Abrahim Al‐Mamgani, et al.. (2023). 888P Phase I study of olaparib combined with loco-regional radiotherapy in patients with head and neck squamous cell carcinoma. Annals of Oncology. 34. S569–S569. 1 indexed citations
2.
Priebe, Marion G., et al.. (2007). Low‐dose acarbose does not delay digestion of starch but reduces its bioavailability. Diabetic Medicine. 24(6). 600–606. 25 indexed citations
3.
Elzinga, H., et al.. (2006). Combined LDI/SAT test to evaluate intestinal lactose digestion and mucosa permeability. European Journal of Clinical Investigation. 36(10). 730–736. 2 indexed citations
4.
Priebe, Marion G., et al.. (2006). Influence of a subsequent meal on the oro‐cecal transit time of a solid test meal. European Journal of Clinical Investigation. 36(2). 123–126. 11 indexed citations
5.
Elzinga, H., et al.. (2004). Beveiliging tegen gevaar dat overlast heet. University of Groningen research database (University of Groningen / Centre for Information Technology). 1. 35–49. 1 indexed citations
6.
Hof, At L., et al.. (2004). Detection of non-standard EMG profiles in walking. Gait & Posture. 21(2). 171–177. 46 indexed citations
7.
Priebe, Marion G., et al.. (2004). Oro‐cecal transit time: influence of a subsequent meal. European Journal of Clinical Investigation. 34(6). 417–421. 13 indexed citations
8.
Hof, At L., et al.. (2002). Speed dependence of averaged EMG profiles in walking. Gait & Posture. 16(1). 78–86. 240 indexed citations
9.
Vonk, Roel J., Frans Stellaard, Marion G. Priebe, et al.. (2001). The 13C/2H‐glucose test for determination of small intestinal lactase activity. European Journal of Clinical Investigation. 31(3). 226–233. 29 indexed citations
10.
Elzinga, H.. (2001). Leerstukken van strafprocesrecht.
11.
Elzinga, H., et al.. (1998). Digestion of starch. European Journal of Gastroenterology & Hepatology. 10(12). A67–A67. 7 indexed citations
12.
Verkade, Henkjan J., et al.. (1997). The 13C‐mixed triglyceride breath test in healthy adults: determinants of the 13CO2 response. European Journal of Clinical Investigation. 27(5). 434–442. 45 indexed citations
13.
Kuipers, Folkert, G.T. Nagel, H. Elzinga, et al.. (1997). O.55 The contribution of newly formed cholesterol to bile salt synthesis in the rat determined by mass isotopomer distribution analysis (MIDA). Clinical Nutrition. 16. 16–16. 1 indexed citations
14.
15.
Hessels, Jan, et al.. (1991). Gas chromatographic determination of N-acetylisoputreanine-γ-lactam, a unique catabolite of N1-acetylspermidine. Journal of Chromatography B Biomedical Sciences and Applications. 563(1). 1–9. 7 indexed citations
16.
17.
Wolthers, B.G., et al.. (1986). The determination of oxalate in haemodialysate and plasma: A means to detect and study ‘hyperoxaluria’ in haemodialysed patients. Clinical Science. 71(1). 41–47. 22 indexed citations
18.
Pavel, S, et al.. (1986). Eumelanin-Related Indolic Compounds in the Urine of Treated Melanoma Patients. Clinical Chemistry and Laboratory Medicine (CCLM). 24(3). 167–73. 16 indexed citations
19.
Pavel, S, et al.. (1983). Identification of 5,6-dimethoxyindolyl-2-carboxylic acid in melanotic urine. Acta Dermato Venereologica. 63(4). 340–343. 8 indexed citations
20.
Keyzer, J. J., H. Breukelman, H. Elzinga, et al.. (1983). Determination of histamine by chemical ionization mass spectrometry: Application to human urine. Journal of Mass Spectrometry. 10(8). 480–484. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Fujimoto Breakdown of academic impact, for papers by Daijiro Abe Breakdown of academic impact, for papers by D Chaleil Breakdown of academic impact, for papers by Hajime Ito Breakdown of academic impact, for papers by M. D. Weidner Breakdown of academic impact, for papers by Chu‐Fen Chang Breakdown of academic impact, for papers by Dimitris Mandalidis Breakdown of academic impact, for papers by Özlem Bölgen Çımen Breakdown of academic impact, for papers by Miroslav Petr Breakdown of academic impact, for papers by J. Mark Brown
Rankless by CCL
2026